Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 598,000 | 264,000 | 1,046,000 | 790,000 | 531,000 |
| Depreciation Amortization | 293,000 | 147,000 | 570,000 | 425,000 | 283,000 |
| Income taxes - deferred | 46,000 | 48,000 | 105,000 | 118,000 | 8,000 |
| Accounts receivable | -259,000 | -180,000 | -106,000 | -153,000 | -115,000 |
| Other Working Capital | -122,000 | -210,000 | 50,000 | -14,000 | -35,000 |
| Other Operating Activity | 319,000 | 209,000 | 221,000 | 255,000 | 186,000 |
| Operating Cash Flow | $875,000 | $278,000 | $1,886,000 | $1,421,000 | $858,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -252,000 | -114,000 | -527,000 | -369,000 | -225,000 |
| Net Acquisitions | -38,000 | -38,000 | -101,000 | -51,000 | -17,000 |
| Other Investing Activity | 4,000 | 0 | -3,000 | -20,000 | 3,000 |
| Investing Cash Flow | $-286,000 | $-152,000 | $-631,000 | $-440,000 | $-239,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 494,000 | 0 | 410,000 | 410,000 | 400,000 |
| Debt Repayment | -501,000 | -1,000 | -1,012,000 | -1,011,000 | -1,001,000 |
| Common Stock Issued | 81,000 | 65,000 | 79,000 | 61,000 | 42,000 |
| Common Stock Repurchased | -102,000 | N/A | -450,000 | -150,000 | N/A |
| Dividend Paid | -206,000 | -88,000 | -353,000 | -306,000 | -203,000 |
| Other Financing Activity | -147,000 | -128,000 | -62,000 | -105,000 | -92,000 |
| Financing Cash Flow | $-381,000 | $-152,000 | $-1,388,000 | $-1,101,000 | $-854,000 |
| Exchange Rate Effect | -2,000 | -1,000 | 4,000 | 3,000 | 5,000 |
| Beginning Cash Position | 420,000 | 420,000 | 549,000 | 549,000 | 549,000 |
| End Cash Position | 626,000 | 393,000 | 420,000 | 432,000 | 319,000 |
| Net Cash Flow | $206,000 | $-27,000 | $-129,000 | $-117,000 | $-230,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 875,000 | 278,000 | 1,886,000 | 1,421,000 | 858,000 |
| Capital Expenditure | -252,000 | -114,000 | -527,000 | -369,000 | -225,000 |
| Free Cash Flow | 623,000 | 164,000 | 1,359,000 | 1,052,000 | 633,000 |